Biogen Inc. buy Truist Financial Co.
Start price
16.05.24
/
50%
€210.90
Target price
16.05.25
€312.83
Performance (%)
-12.19%
Price
30.08.24
€185.20
Summary
This prediction is currently active. The price of Biogen Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.19%. This prediction currently runs until 16.05.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | 1.119% | 1.119% |
iShares Core DAX® | 1.560% | 4.721% |
iShares Nasdaq 100 | 0.517% | 1.171% |
iShares Nikkei 225® | 1.730% | 6.073% |
iShares S&P 500 | 1.482% | 1.218% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $340.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat